7tzt: Difference between revisions

No edit summary
No edit summary
 
Line 1: Line 1:


==Crystal structure of the E. coli thiM riboswitch in complex with N1,N1-dimethyl-N2-(quinoxalin-6-ylmethyl)ethane-1,2-diamine (linked compound 37)==
==Crystal structure of the E. coli thiM riboswitch in complex with N1,N1-dimethyl-N2-(quinoxalin-6-ylmethyl)ethane-1,2-diamine (linked compound 37)==
<StructureSection load='7tzt' size='340' side='right'caption='[[7tzt]]' scene=''>
<StructureSection load='7tzt' size='340' side='right'caption='[[7tzt]], [[Resolution|resolution]] 2.96&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7TZT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7TZT FirstGlance]. <br>
<table><tr><td colspan='2'>[[7tzt]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7TZT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7TZT FirstGlance]. <br>
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7tzt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7tzt OCA], [https://pdbe.org/7tzt PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7tzt RCSB], [https://www.ebi.ac.uk/pdbsum/7tzt PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7tzt ProSAT]</span></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.96&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=KXC:6-methylquinoxaline'>KXC</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7tzt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7tzt OCA], [https://pdbe.org/7tzt PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7tzt RCSB], [https://www.ebi.ac.uk/pdbsum/7tzt PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7tzt ProSAT]</span></td></tr>
</table>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
SignificanceRNA molecules encode proteins and play numerous regulatory roles in cells. Targeting RNA with small molecules, as is routine with proteins, would create broad opportunities for modulating biology and creating new drugs. However, this opportunity has been difficult to realize because creating novel small molecules that bind RNA, especially using modest resources, is challenging. This study integrates two widely used technologies, SHAPE chemical probing of RNA and fragment-based ligand discovery, to craft an innovative strategy for creating small molecules that bind to and modulate the activity of a structured RNA. The anticipated impact is high because the methods are simple, can be implemented in diverse research and discovery contexts, and lead to realistic druglike molecules.
SHAPE-enabled fragment-based ligand discovery for RNA.,Zeller MJ, Favorov O, Li K, Nuthanakanti A, Hussein D, Michaud A, Lafontaine DA, Busan S, Serganov A, Aube J, Weeks KM Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2122660119. doi:, 10.1073/pnas.2122660119. Epub 2022 May 13. PMID:35561226<ref>PMID:35561226</ref>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 7tzt" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Escherichia coli]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Nuthanakanti A]]
[[Category: Nuthanakanti A]]
[[Category: Serganov A]]
[[Category: Serganov A]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA